New Drug Increases Oxygen Uptake, Exercise Capacity in Genetic Heart Disease: Clinical Trial

An international clinical trial found that new drug aficamten boosts exercise capacity and quality of life for obstructive hypertrophic cardiomyopathy patients.

Related Keywords

Massachusetts ,United States ,Burlington ,American ,Steve Ommen ,Martins Maron ,American College Of Cardiology ,Hypertrophic Cardiomyopathy Center At Lahey Hospital ,American Heart Association ,Exercise Longer ,New England Journal ,Hypertrophic Cardiomyopathy Center ,Lahey Hospital ,Medical Center ,Genetic Heart ,American College ,Mayo Clinic ,